OPK — OPKO HEALTH, INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 944809 ·
Last close
$1.62
Market Cap
$1.20B
52W High
$1.86
52W Low
$0.98
ADV30
5,099,443
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 65,414,000 42,063,000 -31,409,000 -53,534,000 1,880,250,000 390,220,000 764,076,000
Jun 2026 163,580,000 80,017,000 -25,042,000 -8,416,000 1,829,453,000 300,761,000 645,287,000
Mar 2026 124,196,000 45,755,000 -51,017,000 -54,848,000 1,856,796,000 341,881,000 652,186,000
Dec 2025 148,450,000 64,025,000 -38,317,000 -31,257,000 1,931,944,000 369,074,000 663,985,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-125,046,000
Investing CF
$22,985,000
Financing CF
$77,945,000
CapEx
$-10,793,000
Dividends Paid
—
Buybacks
$-41,927,000
EPS Diluted TTM
$-0.19
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-2,407,488,000
Inventory
$50,601,000
Receivables
$94,922,000
ST Investments
—
EBIT TTM
$-112,042,000
Pretax Income TTM
$-159,122,000
Interest Exp TTM
$47,080,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$654,096,000
EBITDA
$-91,802,000
Free Cash Flow
$-265,188,256
Enterprise Value
$1,416,148,224
Total Cash
$384,036,000
Total Debt
$515,648,000
Shares Out
742,506,477
Trailing EPS
$-0.16
Book Value
$1.50
ROE
-8.9%
ROA
-5.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 606,879,000 -218,985,000 -225,680,000 1,931,944,000 663,985,000 1,267,959,000 -178,542,000
Dec 2024 713,142,000 -273,558,000 -53,224,000 2,200,212,000 834,764,000 1,365,448,000 -183,489,000
Dec 2023 863,495,000 -158,057,000 -188,863,000 2,011,698,000 622,479,000 1,389,219,000 -28,197,000
Dec 2022 1,004,196,000 -246,124,000 -328,405,000 2,167,259,000 605,611,000 1,561,648,000 -95,189,000

TTM Snapshot

Revenues TTM
$587,896,000
NetIncome TTM
$-72,890,000
OpCashFlow TTM
—
Assets (Latest)
$1,829,453,000
Forward EPS
$-0.34

Max Pain — expiry 2027-01-15

max pain strike: $1.00 · spot: $1.69 · call oi: 22,790 · put oi: 997
Expected Move to 2027-01-15: ±$0.41 (23.96%) — implied range $1.29 – $2.10 · ATM straddle on $1.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
SLNCF Silence Therapeutics plc $1.22B $6.53 —
NKTR NEKTAR THERAPEUTICS $1.23B $35.91 —
AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL $1.23B $13.14 —
SLN Silence Therapeutics plc $1.23B $19.80 —
KARD Kardigan, Inc. $1.23B $13.19 —

News headlines (Yahoo Finance, 1h cache)

Here's Why You Should Retain OPK Stock in Your Portfolio for Now
2026-11-18 16:57 · Yahoo
Is OPKO Health (OPK) A Bargain As New Results And Guidance Reset Valuation?
2026-11-08 01:15 · Yahoo
How Investors May Respond To OPKO Health (OPK) Updated Revenue Guidance
2026-11-08 00:22 · Yahoo
OPKO Health (OPK) Q3 2026 Earnings Call Transcript
2026-11-05 15:13 · Yahoo
What OPKO Health (OPK) Said on Its Q3 Earnings Call
2026-11-05 06:14 · Yahoo
OPKO Health Inc (OPK) (Q3 2026) Earnings Call Highlights: Revenue Climbs 16% as LabCorp Deal ...
2026-11-05 05:20 · Yahoo
OPKO Health (OPK) Reports Q3 Loss, Misses Revenue Estimates
2026-11-04 23:45 · Yahoo
OPKO Health: Q3 Earnings Snapshot
2026-11-04 22:07 · Yahoo
OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results
2026-11-04 21:23 · Yahoo
Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results
2026-11-15 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.